Fmoc-O-trityl-L-homoserine

Fmoc-O-trityl-L-homoserine is a protected L-homoserine derivative in which the α-amino group is masked by an Fmoc (fluorenylmethoxycarbonyl) carbamate and the side-chain hydroxyl is protected as an O-trityl (trityl ether) group, yielding a non-free amino acid suitable for peptide chemistry. The molecule contains an α-carboxyl functional group and a protected α-amino functionality, while the homoserine side chain bears a trityl-protected alcohol that preserves the hydroxyl's position for later deprotection and derivatization; the stereochemistry is specified as L by the product name. In synthesis, the orthogonal protection pattern supports stepwise assembly of peptide or peptide-like structures under conditions that remove the Fmoc group while leaving the trityl ether intact, and it also serves as a precursor for introducing a protected homoserine residue bearing a controllable side-chain hydroxyl handle.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Fmoc-O-trityl-L-homoserine(CAS 111061-55-3)

CAT No: CP06608

CAS No:111061-55-3

Synonyms/Alias:111061-55-3;Fmoc-Hse(Trt)-Oh;Fmoc-HoSer(Trt)-OH;Fmoc-O-trityl-L-homoserine;Fmoc-Homoser(Trt)-OH;n-fmoc-o-trityl-l-homoserine;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-trityloxybutanoic acid;N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-trityl-L-homoserine;MFCD00270544;QUTREFXHXPNEJN-DHUJRADRSA-N;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(trityloxy)butanoic acid;SCHEMBL119491;(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-(trityloxy)butanoic acid;AKOS015896301;HY-W048668;(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-(triphenylmethoxy)butanoic acid;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-(triphenylmethoxy)butanoic acid;AS-59639;DA-53310;CS-0100960;Fmoc-Homoser(Trt)-OH, >=98.0% (HPLC);D94648;N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-trityl-L-homoserine;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C38H33NO5
M.W/Mr.
583.7
Sequence
Three Letter Code:Fmoc-Hse(Trt)(Trt)-OH

Fmoc-O-trityl-L-homoserine is an Fmoc-protected L-homoserine derivative in which the side-chain hydroxyl is masked as an O-trityl ether, while the amino functionality is protected as an Fmoc carbamate. The molecule retains the stereogenic center of L-homoserine and presents a protected primary alcohol equivalent on the side chain, enabling controlled side-chain chemistry after deprotection. The trityl group provides acid-labile protection for the hydroxyl, whereas the Fmoc group supports base-mediated removal under standard peptide synthesis conditions, giving orthogonal deprotection behavior. The resulting chiral, protected amino acid ester/carbamate building block is suitable for peptide coupling and for downstream conversion into side-chain-functionalized homoserine derivatives used in peptide science and synthetic organic chemistry.

1. Protected Amino Acid Synthesis

Fmoc-O-trityl-L-homoserine is applied in protected amino acid synthesis workflows where orthogonal protection is required for sequential functionalization. The Fmoc carbamate protects the α-amino group for iterative peptide coupling, while the O-trityl ether protects the homoserine side-chain hydroxyl from premature acylation or side reactions. The preserved L-configuration supports stereochemically defined incorporation into peptide sequences and chiral intermediate preparation. Orthogonal deprotection enables controlled generation of an amino acid bearing a free side-chain alcohol for subsequent derivatization, making the compound a practical substrate for building block preparation in fine chemical synthesis and peptide manufacturing routes.

2. Peptide Synthesis

Fmoc-O-trityl-L-homoserine is used as a peptide building block in solid-phase peptide synthesis and related protected amino acid chemistry. The Fmoc group enables N-terminal activation and coupling while maintaining the side-chain hydroxyl in a trityl-protected state to prevent uncontrolled esterification during chain assembly. The homoserine side chain can be revealed by trityl removal to permit formation of side-chain-specific linkages, such as hydroxyl-containing peptide variants or further functional group installation. The stereogenic L-center ensures stereochemical fidelity of the incorporated residue, supporting the preparation of defined peptide analogs and enabling downstream synthesis of homoserine-derived peptide fragments for biochemical research and industrial peptide production.

3. Side-Chain Functionalization

Fmoc-O-trityl-L-homoserine is relevant to side-chain functionalization strategies that transform the homoserine hydroxyl into chemically addressable handles. The O-trityl protecting group can be removed under conditions that leave the Fmoc-derived peptide backbone intact during stepwise synthesis, allowing selective conversion of the side-chain alcohol into esters, ethers, or other oxygen-functional derivatives. The retained chiral backbone supports stereodefined products used in SAR studies, peptidomimetic construction, and structure-guided molecular design where side-chain orientation influences binding and recognition. The compound therefore functions as a controlled precursor for generating side-chain-modified amino acid derivatives and peptide analogs used in synthetic methodology development and applied biochemical research.

4. Chemical Biology Labeling

Fmoc-O-trityl-L-homoserine can be employed in chemical biology labeling and biomolecule modification programs that require controlled installation of functional groups at homoserine positions. The protected side-chain alcohol allows incorporation into peptide scaffolds without uncontrolled conjugation, while subsequent deprotection yields a defined hydroxyl site for derivatization into conjugation-ready motifs. The Fmoc-compatible handling supports preparation of labeled peptide probes, linkers, and intermediate fragments used for studying molecular interactions and mapping functional regions in biomolecular systems. The stereochemistry and orthogonal protection pattern help maintain structural integrity of peptide-based constructs during downstream conjugation chemistry, supporting reliable generation of research-grade labeling reagents and analytical standards.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-O-trityl-L-homoserine is suitable for pharmaceutical intermediate preparation where protected amino acid building blocks must withstand manufacturing-relevant synthetic conditions and enable controlled deprotection sequences. The Fmoc group supports standard peptide coupling logic for producing defined protected intermediates, while the acid-labile trityl ether provides a robust temporary mask for the side-chain hydroxyl during upstream steps. The ability to unmask the side-chain alcohol after peptide assembly enables formation of oxygen-functional intermediates that can be carried into further derivatization toward peptide-like active ingredients or processable precursor forms. The compound's chiral homoserine framework and orthogonal protection behavior make it a practical component in industrial fine chemical synthesis and peptide-based manufacturing supply chains.

6. Process Chemistry Intermediate

Fmoc-O-trityl-L-homoserine is applied in process chemistry intermediate design for scalable synthesis of protected homoserine derivatives and peptide building blocks. The orthogonality between base-labile Fmoc removal and trityl ether cleavage supports stepwise manufacturing logic, helping segregate stages that require amino protection from stages that require side-chain hydroxyl availability. The stable protected structure can be handled as a chiral amino acid intermediate, enabling downstream conversion into activated derivatives for coupling or into side-chain-functionalized targets for further synthetic elaboration. The compound's defined stereochemistry and functional group protection pattern support consistent intermediate quality for industrial chemical manufacturing and applied peptide science workflows.

Abbr
Fmoc-Hse(Trt)-OH
InChI
InChI=1S/C38H33NO5/c40-36(41)35(39-37(42)43-26-34-32-22-12-10-20-30(32)31-21-11-13-23-33(31)34)24-25-44-38(27-14-4-1-5-15-27,28-16-6-2-7-17-28)29-18-8-3-9-19-29/h1-23,34-35H,24-26H2,(H,39,42)(H,40,41)/t35-/m0/s1
InChI Key
QUTREFXHXPNEJN-DHUJRADRSA-N
Canonical SMILES
C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)OCCC(C(=O)O)NC(=O)OCC4C5=CC=CC=C5C6=CC=CC=C46

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesiscGMP Peptide ServiceEpitope Mapping ServicesPeptide Analysis ServicesPeptide Synthesis ServicesPeptide CDMOPeptide Modification ServicesCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers